459 related articles for article (PubMed ID: 24251651)
21. A survey of the outcome of prophylaxis, on-demand treatment or combined treatment in 18-35-year old men with severe haemophilia in six countries.
Noone D; O'Mahony B; van Dijk JP; Prihodova L
Haemophilia; 2013 Jan; 19(1):44-50. PubMed ID: 22913831
[TBL] [Abstract][Full Text] [Related]
22. Adherence to clotting factors among persons with hemophilia A or B.
Armstrong EP; Malone DC; Krishnan S; Wessler MJ
Hematology; 2015 Apr; 20(3):148-53. PubMed ID: 25001343
[TBL] [Abstract][Full Text] [Related]
23. Switching haemophilia products and inhibitor risk: a United States' perspective.
Nance D; Rodgers GM
Eur J Haematol; 2015 Apr; 94(4):283. PubMed ID: 25800968
[No Abstract] [Full Text] [Related]
24. Prophylactic factor replacement in hemophilia.
Carcao MD; Aledort L
Blood Rev; 2004 Jun; 18(2):101-13. PubMed ID: 15010149
[TBL] [Abstract][Full Text] [Related]
25. Use of implantable venous access devices in children with severe hemophilia: benefits and burden.
Van Dijk K; Van Der Bom JG; Bax KN; Van Der Zee DC; Van Den Berg MH
Haematologica; 2004 Feb; 89(2):189-94. PubMed ID: 15003894
[TBL] [Abstract][Full Text] [Related]
26. Issues in pediatric haemophilia care.
Giordano P; Franchini M; Lassandro G; Faienza MF; Valente R; Molinari AC
Ital J Pediatr; 2013 Apr; 39():24. PubMed ID: 23601343
[TBL] [Abstract][Full Text] [Related]
27. Haemophilia registries to complement clinical trial data: a pious hope or an urgent necessity?: Reflections on a possible way forward.
Keipert C; van den Berg HM; Keller-Stanislawski B; Hilger A
Haemophilia; 2016 Sep; 22(5):647-50. PubMed ID: 27397094
[No Abstract] [Full Text] [Related]
28. Current situation of regular replacement therapy (prophylaxis) for haemophilia in Japan.
Taki M; Shirahata A
Haemophilia; 2009 Jan; 15(1):78-82. PubMed ID: 18700841
[TBL] [Abstract][Full Text] [Related]
29. Associations between intracranial haemorrhage and prescribed prophylaxis in a large cohort of haemophilia patients in the United States.
Witmer C; Presley R; Kulkarni R; Soucie JM; Manno CS; Raffini L
Br J Haematol; 2011 Jan; 152(2):211-6. PubMed ID: 21114482
[TBL] [Abstract][Full Text] [Related]
30. On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome.
Steen Carlsson K; Höjgård S; Glomstein A; Lethagen S; Schulman S; Tengborn L; Lindgren A; Berntorp E; Lindgren B
Haemophilia; 2003 Sep; 9(5):555-66. PubMed ID: 14511294
[TBL] [Abstract][Full Text] [Related]
31. [Principles of modern therapy for hemophilia A and B in childhood].
Ströder J; Ambs E
Dtsch Med Wochenschr; 1968 Mar; 93(12):539-41. PubMed ID: 5639667
[No Abstract] [Full Text] [Related]
32. The overall effectiveness of prophylaxis in severe haemophilia.
Panicker J; Warrier I; Thomas R; Lusher JM
Haemophilia; 2003 May; 9(3):272-8. PubMed ID: 12694517
[TBL] [Abstract][Full Text] [Related]
33. The use of facoor VIII and factor IX concentrates during surgery.
George JN; Breckenridge RT
JAMA; 1970 Nov; 214(9):1673-6. PubMed ID: 5536529
[No Abstract] [Full Text] [Related]
34. Treatment of haemophilia.
Lancet; 1973 Sep; 2(7830):648-9. PubMed ID: 4125623
[No Abstract] [Full Text] [Related]
35. Adherence to prophylactic infusions of factor VIII or factor IX for haemophilia.
Thornburg CD; Pipe SW
Haemophilia; 2006 Mar; 12(2):198-9. PubMed ID: 16476098
[No Abstract] [Full Text] [Related]
36. Surgery and survival in birth cohorts with severe haemophilia and differences in access to replacement therapy: The Malmö experience.
Osooli M; Steen Carlsson K; Astermark J; Berntorp E
Haemophilia; 2017 Sep; 23(5):e403-e408. PubMed ID: 28758324
[TBL] [Abstract][Full Text] [Related]
37. Prophylaxis in haemophilic children.
Liesner RJ
Blood Coagul Fibrinolysis; 1997 Aug; 8 Suppl 1():S7-10. PubMed ID: 9351529
[TBL] [Abstract][Full Text] [Related]
38. Immune tolerance: critical issues of factor dose, purity and treatment complications.
DiMichele DM
Haemophilia; 2006 Dec; 12 Suppl 6():81-5; discussion 85-6. PubMed ID: 17123399
[TBL] [Abstract][Full Text] [Related]
39. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease.
Rizza CR; Kernoff PB; Matthews JM; McLennan CR; Rainsford SG
Thromb Haemost; 1977 Feb; 37(1):86-90. PubMed ID: 320712
[TBL] [Abstract][Full Text] [Related]
40. Treatment of patients with factor VIII and factor IX inhibitors with special focus on the use of recombinant factor VIIa.
Hedner U
Thromb Haemost; 1999 Aug; 82(2):531-9. PubMed ID: 10605747
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
